Article Information
History
- July 3, 2020.
Article Versions
- Version 1 (July 2, 2020 - 03:02).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Maulin Patel, MD1,#,
- Junad Chowdhury, MD1,
- Nicole Mills, DO1,
- Robert Marron, MD1,
- Andrew Gangemi, MD1,
- Zachariah Dorey-Stein, MD1,
- Ibraheem Yousef, MD1,
- Matthew Zheng, MD1,
- Lauren Tragesser, MS42,
- Julie Giurintano, MS42,
- Rohit Gupta, MD1,
- Parth Rali, MD1,
- Gilbert D’Alonzo, DO1,
- Huaqing Zhao, Phd2,
- Nicole Patlakh, BSc2,
- Nathaniel Marchetti, MD1,
- Gerard J. Criner, MD1,
- Matthew Gordon, MD1,
- for the Temple University COVID-19 Research Group*
- 1Department of Thoracic Medicine and Surgery, Temple University Hospital
- 2Lewis Katz School of Medicine at Temple University
- ↵#Corresponding author; email: maulin.patel{at}tuhs.temple.edu
Posted July 03, 2020.
ROX Index Predicts Intubation in Patients with COVID-19 Pneumonia and Moderate to Severe Hypoxemic Respiratory Failure Receiving High Flow Nasal Therapy
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos